Edward M. Basile, co-leader of King & Spalding’s FDA/life sciences practice, called Morrisey “one of the leading experts in the country on healthcare reform, Medicare and Medicaid issues.
“In addition to representing eight of the top 10 pharmaceutical/biotechnology manufacturers as well as eight of the top 10 medical device manufacturers, King & Spalding also has the largest health care law practice in the nation,” said Basile said in a press release. “Patrick’s arrival simultaneously adds depth to both our regulatory and legislative practices and provides us with an unsurpassed opportunity to counsel clients on the intricacies of the new health care reform law.
Morrisey has successfully represented clients before the Department of Health and Human Services, Centers for Medicare and Medicaid Services and Congress on precedent-setting matters pertaining to coding, coverage and payment of Medicare-related items and services.
Morrisey focuses a large portion of his practice on providing companies with regulatory and legislative analysis and strategic counseling on health care reform.
King & Spalding, which is celebrating 125 years of service, is an international firm with more than 800 lawyers in Abu Dhabi, Atlanta, Austin, Charlotte, Dubai, Frankfurt, Houston, London, New York, Paris, Riyadh (affiliated office), San Francisco, Silicon Valley and Washington, D.C.